JANEEN GASS: Open Payments
NPI 1255504064 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 69 payments from 14 companies in 2025. Trend: 2023 $945 · 2024 $782 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $264 |
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| Lilly USA, LLC | 10 | $146 |
| Novo Nordisk Inc | 6 | $92 |
| PFIZER INC. | 5 | $84 |
| Astellas Pharma US Inc | 3 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Amgen Inc. | 2 | $30 |
Products named: QULIPTA, MOUNJARO, Veozah, GEMTESA, SPRAVATO, LEQVIO, Ozempic, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
